These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 24802511)

  • 1. Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence.
    Aggarwal B; Gogtay J
    Expert Rev Respir Med; 2014 Jun; 8(3):349-56. PubMed ID: 24802511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
    Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors guiding the choice of delivery device for inhaled corticosteroids in the long-term management of stable asthma and COPD: focus on budesonide.
    Thorsson L; Geller D
    Respir Med; 2005 Jul; 99(7):836-49. PubMed ID: 15939245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalatory therapy training: a priority challenge for the physician.
    Melani AS
    Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients.
    Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaler devices for patients with COPD.
    Fink JB; Colice GL; Hodder R
    COPD; 2013 Aug; 10(4):523-35. PubMed ID: 23537191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A narrative review on the Synchrobreathe™: A novel breath-actuated pressurised metered-dose inhaler for the treatment of obstructive airway diseases.
    Lavorini F; Usmani OS; Salvi S; Rote K; Gaur V; Gogtay J
    Respir Med; 2023; 219():107435. PubMed ID: 38652077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of budesonide and formoterol administered via 1 pressurized metered-dose inhaler in patients with asthma and COPD.
    Tronde A; Gillen M; Borgström L; Lötvall J; Ankerst J
    J Clin Pharmacol; 2008 Nov; 48(11):1300-8. PubMed ID: 18974284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler.
    Srichana T; Juthong S; Thawithong E; Supaiboonpipat S; Soorapan S
    Clin Respir J; 2016 Jan; 10(1):74-82. PubMed ID: 25043636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study.
    Sharafkhaneh A; Southard JG; Goldman M; Uryniak T; Martin UJ
    Respir Med; 2012 Feb; 106(2):257-68. PubMed ID: 22033040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-deposition of a triple therapy drug formulation for the treatment of chronic obstructive pulmonary disease using solution-based pressurised metered dose inhalers.
    Adi H; Young PM; Traini D
    J Pharm Pharmacol; 2012 Sep; 64(9):1245-53. PubMed ID: 22881437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budesonide and formoterol in a single pressurized metered-dose inhaler for treatment of COPD.
    Tashkin DP
    Expert Rev Respir Med; 2010 Dec; 4(6):703-14. PubMed ID: 21128746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Evolution of Pressurized Metered-Dose Inhalers from Early to Modern Devices.
    Roche N; Dekhuijzen PN
    J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):311-27. PubMed ID: 26824873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients.
    Dhand R
    Respir Care; 2005 Oct; 50(10):1331-4; discussion 1344-5. PubMed ID: 16185369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhalation devices for long-acting beta2-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD.
    Molimard M; Till D; Stenglein S; Singh D; Krummen M
    Curr Med Res Opin; 2007 Oct; 23(10):2405-13. PubMed ID: 20350055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of breath-actuated inhalers in patients with asthma and COPD - an advance in inhalational therapy: a systematic review.
    Salvi S; Gogtay J; Aggarwal B
    Expert Rev Respir Med; 2014 Feb; 8(1):89-99. PubMed ID: 24325614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseases.
    Ferguson GT; Hickey AJ; Dwivedi S
    Respir Med; 2018 Jan; 134():16-23. PubMed ID: 29413503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of nebulized therapy in the management of COPD: evidence and recommendations.
    Dhand R; Dolovich M; Chipps B; Myers TR; Restrepo R; Farrar JR
    COPD; 2012 Feb; 9(1):58-72. PubMed ID: 22292598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
    Geller DE
    Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.